George Brady

George is a partner in the firm's Corporate Department. He has advised on many of the most significant Irish corporate transactions of recent years including: Allergan’s $66 billion merger with Actavis; unsuccesful bid to acquire eircom from examinership on behalf of an international telecommunications group; the Actavis $8.5 billion acquisition of Warner Chilcott; the $6.5 billion hostile bid by Royalty Pharma for Elan Corporation; Medtronic’s proposed $42.9 billion acquisition of Covidien plc; Eaton Corporation’s $11.8 billion acquisition of Cooper Industries; the $5.6 billion merger of Questcor and Mallinckrodt; Babcock & Brown on its €2.3 billion acquisition of eircom; and the $2.6 billion acquisition of Auxilium Pharmaceuticals by Endo International. George previously worked in the London office of a leading international law firm and has been a partner since 2003. · Matheson LLP

IrelandCorporate / M&A, Commercial

Email Call

About

Partner in Matheson LLP's Corporate Department with extensive experience advising on major Irish and cross-border corporate transactions, including Allergan/Actavis, Actavis’ acquisition of Warner Chilcott, Medtronic’s proposed acquisition of Covidien, and numerous other large M&A deals. Previously worked in the London office of a leading international law firm and has been a partner since 2003.

Practice areas

Corporate / M&ACommercial

Office

Ireland

Matheson LLP · George is a partner in the firm's Corporate Department. He has advised on many of the most significant Irish corporate transactions of recent years including: Allergan’s $66 billion merger with Actavis; unsuccesful bid to acquire eircom from examinership on behalf of an international telecommunications group; the Actavis $8.5 billion acquisition of Warner Chilcott; the $6.5 billion hostile bid by Royalty Pharma for Elan Corporation; Medtronic’s proposed $42.9 billion acquisition of Covidien plc; Eaton Corporation’s $11.8 billion acquisition of Cooper Industries; the $5.6 billion merger of Questcor and Mallinckrodt; Babcock & Brown on its €2.3 billion acquisition of eircom; and the $2.6 billion acquisition of Auxilium Pharmaceuticals by Endo International. George previously worked in the London office of a leading international law firm and has been a partner since 2003.

Ireland

Expertise

Pharmaceuticals & Life SciencesTelecommunicationsCross-border M&A

Education

DePaul University (Law School)
University College Dublin (BCL, International)

Admissions

Admitted to the New York Bar
Qualified as a solicitor of the Supreme Court of England and Wales (non-practising)